rs150170988

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2

The NM_182961.4(SYNE1):​c.10037C>A​(p.Ser3346Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00586 in 1,614,202 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0039 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0061 ( 38 hom. )

Consequence

SYNE1
NM_182961.4 missense

Scores

1
18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 3.03
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SYNE1. . Gene score misZ -0.29069 (greater than the threshold 3.09). Trascript score misZ 3.2909 (greater than threshold 3.09). GenCC has associacion of gene with autosomal recessive ataxia, Beauce type, autosomal recessive myogenic arthrogryposis multiplex congenita, Emery-Dreifuss muscular dystrophy 4, autosomal dominant, arthrogryposis multiplex congenita 3, myogenic type, autosomal dominant Emery-Dreifuss muscular dystrophy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0111064315).
BP6
Variant 6-152364955-G-T is Benign according to our data. Variant chr6-152364955-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 198335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-152364955-G-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 588 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SYNE1NM_182961.4 linkuse as main transcriptc.10037C>A p.Ser3346Tyr missense_variant 63/146 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkuse as main transcriptc.10037C>A p.Ser3346Tyr missense_variant 63/1461 NM_182961.4 ENSP00000356224 P1Q8NF91-1
SYNE1ENST00000423061.6 linkuse as main transcriptc.10058C>A p.Ser3353Tyr missense_variant 63/1461 ENSP00000396024
SYNE1ENST00000471834.1 linkuse as main transcriptn.3175C>A non_coding_transcript_exon_variant 6/191

Frequencies

GnomAD3 genomes
AF:
0.00386
AC:
588
AN:
152202
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00438
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00373
Gnomad FIN
AF:
0.00330
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00606
Gnomad OTH
AF:
0.00287
GnomAD3 exomes
AF:
0.00373
AC:
939
AN:
251488
Hom.:
4
AF XY:
0.00389
AC XY:
529
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00191
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00219
Gnomad FIN exome
AF:
0.00333
Gnomad NFE exome
AF:
0.00616
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00606
AC:
8866
AN:
1461882
Hom.:
38
Cov.:
31
AF XY:
0.00593
AC XY:
4310
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.000717
Gnomad4 AMR exome
AF:
0.00186
Gnomad4 ASJ exome
AF:
0.0000765
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00231
Gnomad4 FIN exome
AF:
0.00354
Gnomad4 NFE exome
AF:
0.00726
Gnomad4 OTH exome
AF:
0.00435
GnomAD4 genome
AF:
0.00386
AC:
588
AN:
152320
Hom.:
1
Cov.:
32
AF XY:
0.00377
AC XY:
281
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.00120
Gnomad4 AMR
AF:
0.00438
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00373
Gnomad4 FIN
AF:
0.00330
Gnomad4 NFE
AF:
0.00606
Gnomad4 OTH
AF:
0.00284
Alfa
AF:
0.00525
Hom.:
6
Bravo
AF:
0.00363
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00640
AC:
55
ExAC
AF:
0.00432
AC:
524
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00594
EpiControl
AF:
0.00605

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024SYNE1: BP4, BS2 -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsSep 21, 2017- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxApr 12, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 18, 2015- -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Autosomal recessive ataxia, Beauce type Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
SYNE1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 27, 2020This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant;C5193121:Arthrogryposis multiplex congenita 3, myogenic type Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 17, 2022- -
Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
15
DANN
Benign
0.84
DEOGEN2
Benign
0.34
T;.;T
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.24
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Benign
0.85
D;T;D
M_CAP
Benign
0.0099
T
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.84
L;.;.
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.4
N;.;N
REVEL
Benign
0.096
Sift
Benign
0.098
T;.;T
Sift4G
Benign
0.19
T;T;T
Polyphen
0.0020
B;.;.
Vest4
0.28
MVP
0.35
MPC
0.17
ClinPred
0.021
T
GERP RS
0.86
Varity_R
0.065
gMVP
0.22

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150170988; hg19: chr6-152686090; COSMIC: COSV99037703; COSMIC: COSV99037703; API